Stay updated on Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial page.

Latest updates to the Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now shows a 403 Forbidden error page instead of the study record content, with the usual header and footer intact.SummaryDifference20%

- Check36 days agoChange DetectedThe page's revision label was updated from v3.6.5 to v3.6.6, indicating a newer version of the page. This change reflects maintenance/version control rather than a substantive content update.SummaryDifference0.1%

- Check57 days agoChange DetectedA new revision tag v3.6.5 was added, superseding the prior v3.6.4. This indicates a minor update to the page's revision history rather than a content change.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page shows a revision update from v3.6.3 to v3.6.4, indicating a minor maintenance update to the ClinicalTrials.gov record. No substantive study information appears to change.SummaryDifference0.0%

- Check92 days agoChange DetectedRevision bumped from v3.6.2 to v3.6.3, indicating a small update to the site’s revision metadata and backend; it does not alter the displayed study details or page structure.SummaryDifference0.0%

- Check100 days agoChange DetectedThe page revision was updated to v3.6.2, replacing v3.6.0, indicating a newer version of the study page content and metadata. This appears to be a minor technical update rather than a substantive change to study information.SummaryDifference0.0%

Stay in the know with updates to Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial page.